NFKB1 and pulmonary arterial hypertension: We therefore performed a detailed immunohistochemical assessment of lung stained for the p65 subunit of NF-κB [34], as well as specific inflammatory cell markers, hypothesizing that NF-κB activation in both inflammatory and pulmonary vascular cells was a feature of patients with end stage idiopathic PAH.